Find a Clinical Trial

In conjunction with our mission to advance the science and practice of clinical psychopharmacology through education and research, ASCP is committed to the support and promotion of clinical trials. We encourage practitioners and patients to investigate and participate in clinical trials when available and appropriate. To list a clinical trial on the website, please submit information to info@ascpp.org.

 

Clinical Trials from Otsuka Pharmaceutical Development & Commercialization, Inc.

  • NCT03287869 A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Bipolar I Disorder

Clinical Trials from Medical University of South Carolina

  • NCT03334721 Gabapentin for Bipolar & Cannabis Use Disorders

Clinical Trials from Axsome Therapeutics, Inc.

  • NCT02741791 A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder (STRIDE-1)
  • NCT03226522 Addressing Dementia Via Agitation-Centered Evaluation (ADVANCE)
  • NCT03595579  Assessing Symptomatic Clinical Episodes in Depression (ASCEND)

Clinical Trials from Azevan Pharmaceuticals

  • NCT02922166 Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans

Clinical Trials from The Cleveland Clinic

  • NCT03113968 ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) (ELEKT-D)

Clinical Trials from Yale University

Clinical Trials from Weill Medical College of Cornell University

  • NCT03026127 A Novel Cognitive Reappraisal Intervention for Suicide Prevention (CRISP)

Clinical Trials from University of Maryland

  • NCT02067975 Tryptophan MRI in People With Schizophrenia and Healthy Controls
  • NCT02884908 Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD

Clinical Trials from Northwell Health

  • NCT02822092 Striatal Connectivity and Clinical Outcome in Psychosis

Clinical Trials from Duke University

  • NCT03069482 Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness

Clinical Trials from Mclean Hospital

  • NCT02188121 Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients (FITNESS)

Clinical Trials from Atlanta Center for Medical Research

  • NCT02932943 A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)

Clinical Trials from University of Nebraska

  • NCT02824627 Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
Clinical Trials from New York State Psychiatric Institute
  • NCT01931202 Mechanisms of Antidepressant Non-Response in Late-Life Depression
  • NCT03169816 Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder
  • NCT02557945 Gabapentin in Patients at Clinical Risk for Psychosis
Clinical Trials from University of Alabama at Birmingham
  • NCT02034253 Glutamate, Brain Connectivity and Duration of Untreated Psychosis (DUP)
Clinical Trials from Florida Atlantic University
  • NCT02717130 Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

 Clinical Trials from Massachusetts General Hospital

  • NCT01246765 National Pregnancy Registry for Atypical Antipsychotics
  • NCT02505984 Preventing Postpartum Depression With Intranasal Oxytocin (IN-OXT)
Clinical Trials from Hartford University
  • NCT02120729 Pharmacogenetic Decision Support IT System for Psychiatric Hospitalization: RCT (CYP-GUIDES)
Clinical Trials from the NIMH
  • NCT02120729 Decision Support IT System for Psychiatric Hospitalization